The Leeds Teaching Hospitals NHS Trust


Getting Started on a Study


If you have a research idea or want to work with another organisation to deliver a study that someone else has developed but involves LTHT patients or resources then you will need confirmation of LTHT Confirmation of capability and capacity

Firstly, if it’s your idea, is it actually research or might it be better described as audit? Essentially “Research” is designed to generate new knowledge and “Audit” is designed to test whether an established service is meeting a defined standard. R&I can help you decide if your proposal is research and you can find further guidance on the Health Research Authority - Decision Tools website where you can also find out whether your study requires HRA Approval.

The Basic Approval Process

If you have a research idea then there are “approvals” you must have in place before you can start to approach patients about your study.

  • HRA Approval (Permission for the study to go ahead in the NHS) this is the new approval that is now required for research to commence in the NHS in England. It comprises an assessment of study compliance with applicable regulations and standards and includes review by an NHS research ethics committee.  
  • Confirmation of capability and capacity from every participating Trust to indicate they can deliver the study in their organisation

You won’t be able to apply for these unless your study has a sponsor. This is the organisation that will be legally responsible for the organisation and management of the study – this is normally an organisation such as a NHS Trust, a University or a commercial company – often your employer.

Sponsored or Hosted Activity?

Do you have an idea for a research proposal that you want to develop and lead? If so your substantive employer (LTHT or UoL) will need to “sponsor” this activity with you as the chief investigator.

You may want to open a study in Leeds that is being sponsored by another organisation – we describe these studies as “hosted” in LTHT.

Sponsored Studies

If you have a research idea then the R&I team will help you obtain the approvals you need to start your study. We can guide you through the regulatory approval process and signpost you to help in developing your study idea to a research protocol. At a minimum you will need to produce;

  • A Protocol
  • A Patient Information Leaflet/Sheet (PIL/PIS)
  • A Consent Form
  • A GP letter

These documents will form the MINIMUM data set to be submitted to the Health Research Authority for review. You can apply to HRA via an online application through the Integrated Research Application System (IRAS) as well as submitting electronically.

For help and support through this process please email the R&I team leedsth-tr.lthtresearch@nhs.net or call 0113 39 20152.

Sponsored Clinical Trials of Investigational Medical Product (CTIMP)

If you have a proposal for a research study that will involve a drug you may be undertaking a Clinical Trials of Investigational Medicinal Product (CTIMP) or drug trial.

CTIMPS are governed by law and subject to inspection by the UK regulator – the Medicines & Healthcare Products Regulatory Agency – MHRA. There are several additional requirements associated with drug trial protocols including how to report safety events, how manage your drug and how to provide assurance on the quality of your study. The Trust and the University have set up a specific section of the R&I team to help you design your trial. Please contact the Quality Assurance (QA) team before you start writing you drug trial protocol.

The QA team will help you design your trial paperwork to ensure it is ethical and legal and help you with all aspects of your study design. QA can provide template to support you through the approval process and guide you once your trial is live.

In LTHT we expect all our researchers to have undergone some research training and for CTIMPs it is a condition of approval that you have undertaken GCP training in the last three years. Please see our training page for more details.

For help and support through the CTIMP approval process please contact mail to Louise Brook (Quality Assurance manager) or call 0113 392 6459

Please also see our key support documents page for templates and guidance and section Governance and Good Clinical Practice.

Where LTHT will be the sponsor of your study

If you wish to submit your study for Confirmation of capability and capacity and Leeds Teaching Hospitals NHS Trust (LTHT) will be the research governance sponsor, please contact the R&I Office and we will help you with your submission to the HRA and advise you on getting confirmation of capability and capacity at LTHT and in your participating sites.

 Where LTHT is not the sponsor of your study

If you wish to take part in a study which is being led by another organisation, the sponsor or chief investigator will provide you with a local study information pack which you will need to run the study here at LTHT. 

The sponsor or chief investigator (CI) will submit these documents direct to the R&I Office or they may ask you to submit the documents to the R&I Office. 

The study documents R&I require in order to start the local organisational approval process for your study are as follows:

  • Protocol and any amendments
  • Patient information sheet  and consent form 
  • IRAS form (combined REC and R&D form) in PDF and .xml format as submitted for HRA Approval
  • *LTHT draft statement of activities (SoA) and draft schedule of events (SoE) (non-commercial studies only)
  • Optional - *model/modified draft LTHT non-commercial agreement. 
  • *model/modified draft LTHT commercial research agreement (commercial studies)
  • *NIHR costing template (validated) and delegation log (including known research team names) (commercial studies only)
  • HRA initial assessment letter and (when issued) HRA approval letter
  • Research passport application for non-LTHT staff only
  • Evidence of GCP training within last 2 years for CTIMP investigators only.

*We will work with you and liaise with the sponsor to finalise draft documents during the assessment process.

Assessing capacity and capability  

First, your CSU (R&I Lead or CSU management team) will need to undertake a capacity and capability (feasibility) assessment for the study (formerly known as CSU approval), that is, consider carefully if the Trust has the capacity and capability to deliver the study safely and effectively, meeting all governance requirements and performance targets.  If your CSU does not have an assessment process in place you may wish to use the R&I capacity and capability assessment guidance and template at http://www.leedsth.nhs.uk/research/information-for-researchers/key-documents/

Arranging key service support approval  

Next, you will need to obtain local key service support approvals from any service departments you may require to support your research including R&I finance approval.  R&I is happy to support you in obtaining these local approvals if required.  Please see department contact details below

 

Department

Name

Email address

R&I Finance

Caryn Lomax (commercial studies)

 

Simon Revesai (non-commercial studies)

Caryn.lomax@nhs.net

 

Simon.revesai@nhs.net

 

Pharmacy

Caroline Bedford/Paula Smalley

leedsth-tr.PharmacyClinicalTrials@nhs.net

 

Radiology

Sheila Boyes

sheilaboyes@nhs.net

 

IRMER

Peter Howells

peterhowells@nhs.net

 

ARSAC

Tania Telford

tania.telford@nhs.net

 

ECG

Sarah Taylor

sarah.taylor92@nhs.net

 

ECHO

 

Sarah Deakin

Julie Sandoval(ECHO Service Manager) (Adults)

Jan Forster (Children’s)

sarah.deakin4@nhs.net

julie.sandoval@nhs.net

 

janforster@nhs.net

 

Labs

Clare Leeming

c.leeming@nhs.net

 

Histopathology

Olorunda Rotimi

olorunda.rotimi@nhs.net

 

Cytogenetics/DNA

Miranda Squires

miranda.squires@nhs.net

 

Ophthalmology

Jen Green

Ian Simmons

jen.green1@nhs.net

i.simmons@nhs.net

 

HMDS

Sharon Barrans

sharon.barrans@nhs.net

 

Phlebotomy

Mary Simpson

 

mary.simpson11@nhs.net

 

Completing the statement of activities and schedule of events (non-commercial studies)

If your study is non-commercial, the sponsor of your study will have prepared a statement of activities (SoA) and schedule of events (SoE) to capture all the information around study activities to be undertaken at a local level.  A template SoA and SoE will be reviewed and approved by the HRA for the each type of participating site to ensure that there is clarity on the resource implications for participating NHS organisations delivering research within an NHS organisation.  This then needs to be finalised during the Trust level assessment process with all the local requirements for LTHT.  The sponsor is responsible for completing these documents in discussion with you.  R&I can support you in this process.

Research agreement completion (commercially sponsored studies) arranging key service support

If your study is commercial the sponsor of your study will have prepared a model/modified draft LTHT commercial research agreement. Review of Confidentiality and research agreements will usually be undertaken by Research & Innovation Coordinator’s, they will review, liaise with the sponsor and finalise the agreement. 

Once we have finalised the agreement we will sign it off on behalf of LTHT when we issue the LTHT Confirmation of capability and capacity email (see below).

LTHT Confirmation of capability and capacity

A study cannot proceed without LTHT Confirmation of capability and capacity. Once all the above stages have been completed (feasibility review, arrangement of key service support approvals, SoA and SoE or agreements finalised) R&I will issue an LTHT Confirmation of capability and capacity email (along with a fully executed/signed agreement, and an authorised SoA and SoE).  This email signals that the study can begin at LTHT. 

Further guidance and information please contact the R&I Team: leedsth-tr.lthtresearch@nhs.net